跳至主要内容
临床试验/NCT02745379
NCT02745379Unknown1 期

Effect of Buccal Fat Pad Derived Mesenchymal Stem Cells Loaded on Allograft and Platelet-rich Plasma in Maxillary Sinus Augmentation

Shahid Beheshti University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年1月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
入组人数
20
试验地点
1
主要终点
amount of regenerated bone

研究概览

简要总结

In this study the buccal fat pad derived stem cells (BFPSCs) will be harvested from buccal fat pad tissue of patients receiving maxillary sinus augmentation. In the test group the patients receive a combination of platelet rich fibrin (PRF) and freeze dried bone allograft (FDBA) (SureOss, Hansbiomed, Korea) loaded with BFPSCs. The results will be evaluated by cone beam computed tomography (CBCT)and hematoxylin and eosin staining in 6 months.

详细描述

The buccal fat pad derived stem cells (BFPSCs) is harvested from buccal fat pad tissues. The BFPSCs will be loaded on freeze dried bone allograft (FDBA) (SureOss, Hansbiomed, Korea). Furthermore, twenty milliliters of the venous blood is obtained, placed and collected in a sterile tube, and centrifuged (GAC medical) for 14 minutes at 2800 rpm (approximately 400 g). Following centrifugation, three layers are separated in the tube: cellular plasma at the top, platelet rich fibrin (PRF) clot in the middle and red blood cells at the bottom of the tube. The PRF clot is separated by a sterile pincette.

The patients in the test group receives BFPSCs loaded on DFDBA with PRF for sinus augmentation and the control group receives combination of PRF and DFDBA (lacking any cells).The results will be evaluated by cone beam computed tomography (CBCT) in 6 months and microscopic evaluation of the biopsies by hematoxylin and eosine staining.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •patients with posterior maxillary edentulism
  • •pneumatized sinus
  • •less than 5mm bone height between the alveolar crest and sinus membrane

排除标准

  • •history of malignancy
  • •chemotherapy
  • •systemic diseases contradicting dental and surgical treatments
  • •conditions or drugs affecting bone remodeling or bone metabolism and connective tissue
  • •allergy to collagen

研究组 & 干预措施

BFPSC+

Experimental

The group receives a combination (DFDBA)+buccal fat pad derived stem cells BFPSC and PRF for sinus augmentation

干预措施: BFPSCs+ DFDBA+ PRF (Procedure)

BFPSC-

Active Comparator

The group receives a combination of demineralized freeze-dried bone allografts DFDBA (lacking any cells) and PRF for sinus augmentation

干预措施: DFDBA + PRF (Procedure)

结局指标

主要结局

amount of regenerated bone

时间窗: 6 months

the amount of regenerated bone will be assessed by Image Pro software in CBCT images

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Arash Khojasteh

Associate professor

Shahid Beheshti University of Medical Sciences

研究点 (1)

Loading locations...

相似试验